Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acetylsalicylic Acid Lysinate
2. Aspegic
3. Aspirin Lysinate
4. Aspirin Lysine
5. Aspiryl-polylysine
6. Aspisol
7. Asprin Dl-lysine
8. Flectadol
9. L-lysine, 2-(acetyloxy)benzoate (1:1)
10. Lysine Acetylsalicylate
11. Lysine-acetylsalicylic Acid
12. Lysine-aspirin
13. Solusprin
14. Solusprin, Monosalicylate, (dl-lys)-isomer
15. Solusprin, Monosalicylate, (l-lys)-isomer
16. Venopirin
1. Dl-lysine Acetylsalicylate
2. 62952-06-1
3. Aspegic
4. Egicalm
5. Aspirisine
6. Aspidol
7. Solpirin
8. Venopirin
9. Vetalgine
10. Dl-lysine-acetylsalicylate
11. Flectadol
12. Laspal
13. L-lysine Acetylsalicylate
14. Lysine Acetylsalicylic Acid
15. Asl
16. Lysine Acetylsalicylate,(s)
17. Schembl25877
18. 2-acetoxybenzoic Acid (1:1)
19. Lysine Aspirin [mart.]
20. Chembl1697753
21. Dtxsid50886518
22. Bcp12010
23. Lysine Acetylsalicylate [mi]
24. Akos025402349
25. 2,6-diaminohexanoic Acid Compound With
26. Ac-8243
27. Dl-lysine Acetylsalicylate, Aldrichcpr
28. Acetylsalicylate Lysine [who-dd]
29. Ft-0670894
30. Dl-lysine Acetylsalicylate [ep Monograph]
31. 952l061
32. Q15041214
Molecular Weight | 326.34 g/mol |
---|---|
Molecular Formula | C15H22N2O6 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 8 |
Exact Mass | 326.14778643 g/mol |
Monoisotopic Mass | 326.14778643 g/mol |
Topological Polar Surface Area | 153 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 318 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
M2i Group, an integrated CDMO, is your French partner for development & manufacturing in fine chemistry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8468
Submission : 1990-03-12
Status : Inactive
Type : II
Global Sales Information
Market Place
ABOUT THIS PAGE
A Aspirin Lysinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aspirin Lysinate, including repackagers and relabelers. The FDA regulates Aspirin Lysinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aspirin Lysinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aspirin Lysinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aspirin Lysinate supplier is an individual or a company that provides Aspirin Lysinate active pharmaceutical ingredient (API) or Aspirin Lysinate finished formulations upon request. The Aspirin Lysinate suppliers may include Aspirin Lysinate API manufacturers, exporters, distributors and traders.
click here to find a list of Aspirin Lysinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aspirin Lysinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Aspirin Lysinate active pharmaceutical ingredient (API) in detail. Different forms of Aspirin Lysinate DMFs exist exist since differing nations have different regulations, such as Aspirin Lysinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aspirin Lysinate DMF submitted to regulatory agencies in the US is known as a USDMF. Aspirin Lysinate USDMF includes data on Aspirin Lysinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aspirin Lysinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aspirin Lysinate suppliers with USDMF on PharmaCompass.
Aspirin Lysinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aspirin Lysinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aspirin Lysinate GMP manufacturer or Aspirin Lysinate GMP API supplier for your needs.
A Aspirin Lysinate CoA (Certificate of Analysis) is a formal document that attests to Aspirin Lysinate's compliance with Aspirin Lysinate specifications and serves as a tool for batch-level quality control.
Aspirin Lysinate CoA mostly includes findings from lab analyses of a specific batch. For each Aspirin Lysinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aspirin Lysinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Aspirin Lysinate EP), Aspirin Lysinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aspirin Lysinate USP).
LOOKING FOR A SUPPLIER?